Last ¥589.00 JPY
Change Today 0.00 / 0.00%
Volume 0.0
4556 On Other Exchanges
Symbol
Exchange
Tokyo
Frankfurt
As of 1:36 AM 08/21/14 All times are local (Market data is delayed by at least 15 minutes).

kainos laboratories inc (4556) Snapshot

Open
¥580.00
Previous Close
¥580.00
Day High
¥596.00
Day Low
¥580.00
52 Week High
01/24/14 - ¥725.00
52 Week Low
09/2/13 - ¥460.00
Market Cap
2.7B
Average Volume 10 Days
19.1K
EPS TTM
¥48.98
Shares Outstanding
4.6M
EX-Date
03/27/15
P/E TM
12.0x
Dividend
¥7.50
Dividend Yield
1.27%
Current Stock Chart for KAINOS LABORATORIES INC (4556)

Related News

No related news articles were found.

kainos laboratories inc (4556) Related Businessweek News

No Related Businessweek News Found

kainos laboratories inc (4556) Details

KAINOS Laboratories, Inc. develops, manufactures, markets, distributes, and imports/exports pharmaceuticals, diagnostic reagents, related chemical products, physical and chemical measurement instruments, medical supplies, nutrition supplements, foodstuff, animal feed, and related products in Japan. The company offers various biochemical clinical testing reagents systems, such as Aqua-auto Kainos series for automated analysis equipment; MP-EIA series for automated EIA equipment QUARTUS ImmunoCube; Lana 1,5AG, a high-sensitivity diabetes diagnostic reagent and a family of immunoserological testing reagents; MAST, an allergic diagnostic reagent; and Hitazyme Chlamydia for infectious diseases. It also provides FGF-23 ELISA Kit, a two-site enzyme-linked immunosorbent assay kit for the measurement of FGF-23 in serum; and ADAMTS13 ELISA kit that captures ADAMTS13-cleaved products using a sandwich method. In addition, the company offers biochemical diagnostic reagents, including Aqua-auto Kainos UN-II test kit, a liquid form urea nitrogen measurement reagent kit; Aqua-auto Kainos CRE-II test kit, a liquid form creatinine measurement reagent kit; and Aqua-auto Kainos ALB test kit, a liquid form reagent kit. Further, it provides Swiftgene Norovirus GI/GII Kainos for detecting noroviruses; Statmark FLUstickAB for detecting Type A and Type B influenza virus antigens; and Statmark Strep A for detecting Group A-b hemolytic streptococci. The company was formerly known as DOMS-IATRON Co., Ltd. and changed its name to KAINOS Laboratories, Inc. in July 1975. KAINOS Laboratories, Inc. was founded in 1975 and is headquartered in Tokyo, Japan.

Founded in 1975

kainos laboratories inc (4556) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kainos laboratories inc (4556) Key Developments

Kainos Laboratories, Inc. to Report Q1, 2015 Results on Jul 25, 2014

Kainos Laboratories, Inc. announced that they will report Q1, 2015 results on Jul 25, 2014

Kainos Laboratories, Inc., Annual General Meeting, Jun 19, 2014

Kainos Laboratories, Inc., Annual General Meeting, Jun 19, 2014.

Kainos Laboratories, Inc., 2014 Earnings Call, May 19, 2014

Kainos Laboratories, Inc., 2014 Earnings Call, May 19, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4556:JP ¥589.00 JPY 0.00

4556 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4556.
View Industry Companies
 

Industry Analysis

4556

Industry Average

Valuation 4556 Industry Range
Price/Earnings 24.8x
Price/Sales 0.5x
Price/Book 0.8x
Price/Cash Flow 16.7x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KAINOS LABORATORIES INC, please visit www.kainos.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.